Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Myasthenia gravis with antibodies to MuSK: an update.

Evoli A, Alboini PE, Damato V, Iorio R, Provenzano C, Bartoccioni E, Marino M.

Ann N Y Acad Sci. 2018 Jan;1412(1):82-89. doi: 10.1111/nyas.13518. Epub 2017 Dec 21. Review.

PMID:
29266255
2.

Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis.

Guptill JT, Sanders DB.

Curr Opin Neurol. 2010 Oct;23(5):530-5. doi: 10.1097/WCO.0b013e32833c0982. Review.

PMID:
20613516
3.

Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.

Evoli A, Tonali PA, Padua L, Monaco ML, Scuderi F, Batocchi AP, Marino M, Bartoccioni E.

Brain. 2003 Oct;126(Pt 10):2304-11. Epub 2003 Jun 23.

PMID:
12821509
4.

Diagnosis and therapy of myasthenia gravis with antibodies to muscle-specific kinase.

Evoli A, Padua L.

Autoimmun Rev. 2013 Jul;12(9):931-5. doi: 10.1016/j.autrev.2013.03.004. Epub 2013 Mar 25. Review.

PMID:
23535158
5.

Anti-MuSK myasthenia gravis presenting with purely ocular findings.

Caress JB, Hunt CH, Batish SD.

Arch Neurol. 2005 Jun;62(6):1002-3.

PMID:
15956173
6.

MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.

Farrugia ME, Robson MD, Clover L, Anslow P, Newsom-Davis J, Kennett R, Hilton-Jones D, Matthews PM, Vincent A.

Brain. 2006 Jun;129(Pt 6):1481-92. Epub 2006 May 3.

PMID:
16672291
7.

Clinical and scientific aspects of muscle-specific tyrosine kinase-related myasthenia gravis.

Reddel SW, Morsch M, Phillips WD.

Curr Opin Neurol. 2014 Oct;27(5):558-65. doi: 10.1097/WCO.0000000000000136. Review.

PMID:
25159928
8.

Management challenges in muscle-specific tyrosine kinase myasthenia gravis.

Evoli A, Alboini PE, Bisonni A, Mastrorosa A, Bartoccioni E.

Ann N Y Acad Sci. 2012 Dec;1274:86-91. doi: 10.1111/j.1749-6632.2012.06781.x. Erratum in: Ann N Y Acad Sci. 2013 Apr;1283:102. Bartocccioni, Emanuela [corrected to Bartoccioni, Emanuela].

PMID:
23252901
9.

Successful treatment of MuSK antibody-positive myasthenia gravis with rituximab.

Hain B, Jordan K, Deschauer M, Zierz S.

Muscle Nerve. 2006 Apr;33(4):575-80.

PMID:
16323216
10.
11.

Mechanisms associated with the pathogenicity of antibodies against muscle-specific kinase in myasthenia gravis.

Mori S, Shigemoto K.

Autoimmun Rev. 2013 Jul;12(9):912-7. doi: 10.1016/j.autrev.2013.03.005. Epub 2013 Mar 26. Review.

PMID:
23537506
12.

MuSK-Ab positive myasthenia: not always grave.

Zouvelou V, Stamboulis E, Skriapa L, Tzartos SJ.

J Neurol Sci. 2013 Aug 15;331(1-2):150-1. doi: 10.1016/j.jns.2013.05.001. Epub 2013 May 23.

PMID:
23706725
13.

Myasthenia gravis with muscle-specific tyrosine kinase antibodies: A narrative review.

Morren J, Li Y.

Muscle Nerve. 2018 Sep;58(3):344-358. doi: 10.1002/mus.26107. Epub 2018 Mar 25. Review.

PMID:
29461627
14.

Pattern of ocular involvement in myasthenia gravis with MuSK antibodies.

Evoli A, Alboini PE, Iorio R, Damato V, Bartoccioni E.

J Neurol Neurosurg Psychiatry. 2017 Sep;88(9):761-763. doi: 10.1136/jnnp-2017-315782. Epub 2017 Jun 10.

PMID:
28601810
15.

Muscle-specific receptor tyrosine kinase antibody-positive and seronegative myasthenia gravis.

Muppidi S, Wolfe GI.

Front Neurol Neurosci. 2009;26:109-19. doi: 10.1159/000212372. Epub 2009 Apr 6. Review.

PMID:
19349708
16.

Maintenance plasma exchange treatment for muscle specific kinase antibody positive myasthenia gravis patients.

Yamada C, Teener JW, Davenport RD, Cooling L.

J Clin Apher. 2015 Oct;30(5):314-9. doi: 10.1002/jca.21377. Epub 2014 Dec 30.

17.

Myasthenia gravis patients with anti-MuSK antibodies.

Zagar M, Vranjes D, Sostarko M, Vogrinc Z, Bilić E, Trbojević Cepe M.

Coll Antropol. 2009 Dec;33(4):1151-4.

PMID:
20102061
18.

MuSK antibody-positive, seronegative myasthenia gravis in Korea.

Lee JY, Sung JJ, Cho JY, Oh DH, Kim HJ, Park JH, Lee KW, Choi YC, Vincent A.

J Clin Neurosci. 2006 Apr;13(3):353-5. Epub 2006 Mar 20.

PMID:
16546389
19.

Anti-MuSK-Positive Myasthenia Gravis in a Patient with Parkinsonism and Cognitive Impairment.

Lanfranconi S, Corti S, Baron P, Conti G, Borellini L, Bresolin N, Bersano A.

Neurol Res Int. 2011;2011:859802. doi: 10.1155/2011/859802. Epub 2011 Jul 31.

20.

Selective response to rituximab in a young child with MuSK-associated myasthenia gravis.

Govindarajan R, Iyadurai SJ, Connolly A, Zaidman C.

Neuromuscul Disord. 2015 Aug;25(8):651-2. doi: 10.1016/j.nmd.2015.03.014. Epub 2015 Apr 22.

PMID:
25998611

Supplemental Content

Support Center